T36.AX2
Poisoning by fluoroquinolone antibiotics, intentional self-harm
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 code T36.AX2 refers to cases where individuals intentionally harm themselves by poisoning with fluoroquinolone antibiotics. These medications are commonly prescribed to treat bacterial infections, but misuse or overdose can lead to serious health complications. This article provides an overview to help understand the causes, symptoms, diagnosis, and general treatment considerations related to this specific type of poisoning.
Causes & Symptoms
Clinical Causes: Intentional self-harm or suicide attempt using fluoroquinolone antibiotics Misuse or abuse of antibiotics due to mental health issues Lack of awareness about the potential risks of these medications Absence of proper medical supervision during medication use
Key Symptoms: Gastrointestinal disturbances such as nausea, vomiting, or diarrhea Neurological effects including dizziness, headache, or confusion Tendinitis or joint pain in more severe cases Sensory disturbances like numbness or tingling Serious reactions such as tendon rupture or nerve damage
Diagnostic & Treatment
Diagnosis Path: Diagnosis is primarily based on recent history of fluoroquinolone intake combined with clinical symptoms. Healthcare professionals may conduct blood tests to detect elevated medication levels, evaluate organ functions, or identify signs of systemic toxicity. It's important to differentiate intentional poisoning from accidental overdose, often requiring psychological assessment and detailed patient history.
Treatment Protocols: Management typically involves supportive care tailored to the patient's symptoms and severity of poisoning. This may include:
Clinical Advice & FAQs
Billing Guidance
Is T36.AX2 a billable ICD-10 code?
Yes, T36.AX2 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report T36.AX2?
Clinical documentation must specify the nature of Poisoning by fluoroquinolone antibiotics, intentional self-harm and any associated comorbidities for accurate reporting.
Cite this Clinical Reference